In this section
- Access to general practitioners on the Central Coast, New South Wales
- Australian Government subsidy of Continuous Glucose Monitors
- Ban on cosmetic testing on animals
- E-cigarettes
- headspace Centre for the City of Monash
- Health Workforce Safety in Remote Australia
- Immunisation
- Labelling of added sugar
- Medicare Benefits Schedule (MBS) rebate for minimally invasive glaucoma surgery (MIGS) devices.
- My Health Record National opt out
- National Ice Action Strategy
- Ophthalmologists response to a restriction on claiming Medicare Benefits Schedule (MBS) attendance items with Surgical Operations that have an MBS fee of $300 or more
- Primate Experiments
- Support for Labelling Logic Recommendation 12: palm oil
- The Australian Government listed nusinersen on the Pharmaceutical Benefits Scheme (PBS) from 1 June 2018 for the treatment of Type 1, Type 2 and Type 3a spinal muscular atrophy (SMA)
- The Medical Board of Australia's draft proposed Good medical practice: a code of conduct for doctors
- Tobacco Excise
- Two Tier Medicare Rebate System for Psychological Therapy Services